section 8
on 21 Aug 2015
Last Applicant/ Owned by
Roslagsbacken 15
Stockholm
SE
10691
Serial Number
78961832 filed on 28th Aug 2006
Registration Number
3566066 registered on 20th Jan 2009
Correspondent Address
Lawrence J. Crain
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceutical substances based on affinity reagents of immunoglobulin or non-immunoglobulin origin for cancer diagnostics, prognostics, and treatment; pharmaceutical preparations for molecular or cellular targeting, protein detection, and in-vivo imaging, mainly for cancer cells, in-vitro or in-vivo, all for medical or diagnostic purposes; biological preparations for pharmaceutical use for cancer Read More
Pharmaceutical substances based on affinity reagents of immunoglobulin or non-immunoglobulin origin for cancer diagnostics, prognostics, and treatment; pharmaceutical preparations for molecular or cellular targeting, protein detection, and in-vivo imaging, mainly for cancer cells, in-vitro or in-vivo, all for medical or diagnostic purposes; biological preparations for pharmaceutical use for cancer diagnostics, prognostics, and treatment
28th Aug 2006
28th Aug 2006
Scientific and medical research and developments within the field of biochemistry and biotechnology, diagnostics and pharmaceutical or medical substances and preparations
29th Oct 2006
29th Oct 2006
No 78961832
No Service Mark
No 1819.75885
No
No
No
No
No
No
No
No
26.01.21 -
Circles that are totally or partially shaded
Status Date | Action Taken |
---|---|
21st Aug 2015 | CANCELLED SEC. 8 (6-YR) |
20th Jan 2009 | REGISTERED-PRINCIPAL REGISTER |
18th Dec 2008 | LAW OFFICE REGISTRATION REVIEW COMPLETED |
17th Dec 2008 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
05th Dec 2008 | STATEMENT OF USE PROCESSING COMPLETE |
03rd Dec 2008 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
26th Nov 2008 | TEAS STATEMENT OF USE RECEIVED |
26th Nov 2008 | USE AMENDMENT FILED |
22nd Jul 2008 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
29th Apr 2008 | PUBLISHED FOR OPPOSITION |